What If Addiction Treatment in Atlanta Hasn’t Worked? Understanding Why People Relapse After Detox or Rehab
DeBinge opioid transition: When travelling to DeBinge in The Bahamas for OLANI treatment, there is no requirement to complete a separate opioid-free waiting window before arrival. DeBinge uses a medically supervised 4-to-5-day buprenorphine transition. Buprenorphine is introduced to bridge the patient away from full-agonist opioids, stabilised and tapered over the first several days, and the O’Neil Long-Acting Naltrexone Implant is typically inserted around day 4 or 5 while buprenorphine is still being tapered. The planned overlap continues as buprenorphine clears and the implant gradually releases naltrexone. This pathway is clinician-supervised because mistimed naltrexone exposure can precipitate withdrawal.
Based on DeBinge’s clinical experience in The Bahamas since 2018, the implant typically provides its strongest craving and relapse-prevention support on average 9 months, while clinically meaningful opioid-receptor blockade may persist for longer, in some patients up to about 15 months. This longer blockade may continue to reduce opioid effects and overdose risk.
Ongoing recovery: The implant is not a cure. The DeBinge programme includes a full year of professional counselling after implantation to address the behavioural and psychological side of addiction.
You went through detox. You completed rehab. Maybe your family believed the worst part was finally behind you. Then, weeks or months later, alcohol or drugs returned to your life.
The question that often follows is painful: “Why did I relapse if I already had treatment?”
The answer is rarely that simple. A return to substance use does not automatically mean the previous treatment was useless, that you did not try hard enough, or that recovery is impossible. It may mean that one or more parts of the treatment and recovery plan need to be reassessed, strengthened or changed.
A better clinical question is: “What worked during treatment, what changed afterward, and what needs to be different next time?”
Understanding What Happens After Treatment
Relapse Does Not Usually Have One Single Cause
Addiction treatment can produce meaningful improvement while someone is in a highly structured environment. The harder test often comes afterward, when normal life returns.
A person may leave detox or residential rehab highly motivated and still encounter several risks at the same time: strong cravings, poor sleep, relationship conflict, easy access to substances, old friends, untreated anxiety or depression, financial pressure, boredom, medication that was stopped early, missed counseling and long periods without structure.
The National Institute on Drug Abuse has long described substance use disorders as conditions that can require ongoing management. A recurrence of use can signal a need to restart, modify or intensify treatment rather than conclude that treatment is pointless.
Biology
Craving, reward learning, withdrawal, reduced tolerance and responses to stress can remain relevant after treatment.
Psychology
Emotional distress, trauma-related symptoms, depression, anxiety and established coping patterns may continue.
Environment
People, places, routines, money, social settings and easy substance access can reactivate learned patterns.
This is especially important for someone in Atlanta who has already tried local detox, residential treatment or outpatient care and is now investigating treatment options for Atlanta residents. Previous treatment history should become information for the next clinical plan rather than something to hide or dismiss.
Detoxification and Long-Term Recovery Are Not the Same Thing
Detoxification has an important medical purpose. It manages the acute physical effects of stopping a substance and can be essential when withdrawal may be dangerous or difficult to manage safely.
But detox is not designed to solve every part of addiction.
NIDA’s principles of addiction treatment explain that detoxification manages the physiological effects of stopping drugs, but detoxification alone generally does not address the psychological, social and behavioral problems associated with addiction. It is normally a first stage that should be followed by appropriate addiction treatment.1
Think of detox as stabilization, not completion
Detox can help someone cross the immediate withdrawal stage. Long-term recovery then has to address what happens when stress returns, cravings appear, relationships become difficult, access to substances returns and the person is once again making decisions without 24-hour structure.
This distinction helps explain why someone can complete detox successfully and still return to substance use later. The detox may have done exactly what it was intended to do. The vulnerability may have appeared in the next stage of care.
Detox, Rehab, Outpatient Care and Medication Do Different Things
| Type of care | Primary purpose | What it may address | What usually still needs planning |
|---|---|---|---|
| Medical detoxification | Manage withdrawal and immediate medical stabilization. | Acute physical dependence and withdrawal-related risk. | Behavior change, triggers, ongoing medication, therapy, environment and continuing care. |
| Residential rehabilitation | Provide intensive treatment in a structured living environment. | Therapy, education, stabilization, routine, recovery skills and separation from some triggers. | How those skills will transfer into everyday life after discharge. |
| Outpatient treatment | Provide treatment while someone continues living in the community. | Therapy, accountability, medication management and practical recovery work. | Level of care, attendance, environmental risk and sufficient intensity. |
| Medication-based treatment | Address specific biological aspects of alcohol or opioid use disorder where appropriate. | Depending on the medication, withdrawal, craving, opioid receptor activity or substance reward. | Adherence, counseling, mental health, social environment and broader recovery needs. |
| Counseling / behavioral therapy | Change learned responses, coping patterns and behavior. | Triggers, coping skills, motivation, relationships, stress and relapse planning. | Medical needs, medication when indicated and practical support outside sessions. |
| Continuing care | Maintain treatment gains after more intensive care ends. | Follow-up, accountability, therapy, support and adapting the plan as life changes. | Ongoing reassessment if risk increases or substance use returns. |
The important point is that these are not interchangeable. Someone can complete one stage successfully while still needing another.
Cravings and Learned Cues Can Persist After Treatment
During repeated substance use, the brain can learn powerful associations between alcohol or drugs and the circumstances surrounding their use.
A particular person, neighborhood, payday, hotel, bar, bedroom, music track, emotional state or time of day can become associated with the expectation of a substance. Later, encountering the same cue can activate thoughts or cravings even after a period of abstinence.
This helps explain an experience that can be confusing for people leaving treatment: “I was doing well. Then something happened and suddenly I wanted to use again.”
Cue
A familiar person, place, emotion or situation appears.
Association
The brain recognizes something previously linked with substance use.
Craving
Attention shifts toward the substance or the relief previously associated with it.
Response
A prepared recovery response is needed before risk increases further.
Cravings do not mean treatment was worthless, and they do not guarantee a return to use. They do mean the recovery plan needs practical ways to recognize and respond to high-risk moments.
The Environment Can Be Part of the Relapse Pattern
Imagine someone leaves residential treatment feeling stronger, healthier and clearer. For several weeks, substances were unavailable, days were structured and support was nearby.
Then they return to Metro Atlanta.
The apartment may be the same. The phone still contains old contacts. The route home from work passes familiar places. Weekends become unstructured again. A person they previously drank or used with sends a message. Family conflict starts again. Money becomes available on payday.
For someone living in Buckhead, Midtown, Decatur, Sandy Springs, Marietta, Alpharetta, Roswell or elsewhere in the Atlanta region, the issue is not that the neighborhood itself causes addiction. The issue is that an individual’s personal environment may contain cues, relationships and routines strongly connected with previous substance use.
Why Returning Home Can Be a Vulnerable Point
Residential treatment can provide something everyday life cannot: a controlled environment with intensive structure and reduced exposure to many external triggers.
That can be extremely useful. The difficulty is that the person eventually has to transfer what they learned into normal life.
A plan that works well inside treatment may need adaptation for a 7 a.m. commute, a difficult employer, child-care responsibilities, family disagreements, social events, insomnia, loneliness at night or sudden access to drugs or alcohol.
Before discharge, the practical question should therefore become: “What will an ordinary Tuesday at home actually look like?”
- What time will you wake up and go to sleep?
- What happens during the hours previously associated with substance use?
- Which people need stronger boundaries?
- Who will know if cravings start increasing?
- When is the first counseling appointment?
- How will prescribed medication be continued?
- What happens when boredom or isolation appears?
- Where will you go if home suddenly becomes a high-risk environment?
One Missing Piece May Be Continuing Care
The end of residential treatment should not necessarily mean the end of active treatment.
Research on continuing care for substance use disorders has generally found benefit, although effects vary across programs and populations. A meta-analysis of controlled studies found a modest but statistically significant benefit from continuing care, and later research has emphasized that longer-duration care and active efforts to maintain engagement can be particularly important for some higher-risk patients.2 3
Atlanta providers commonly describe aftercare in terms of counseling, relapse-prevention planning, support groups and referrals. Those can all be useful. The deeper question is whether the aftercare plan is specific enough and intensive enough for the person who is actually going home.
Before discharge
Appointments should ideally be arranged, not simply recommended in general terms.
During early recovery
Cravings, attendance, sleep, mood, medication and exposure to triggers can be reviewed regularly.
When risk changes
The plan should become more intensive when warning signs appear rather than waiting for another crisis.
Untreated Mental Health Needs Can Make Recovery Harder
Substance use and mental health conditions often overlap. Anxiety, depression, post-traumatic stress, bipolar disorder and other psychiatric problems may exist before substance use, develop alongside it or become more noticeable after substances are removed.
SAMHSA recommends integrated attention to co-occurring mental health and substance use disorders rather than treating them as completely separate problems.4
This matters after relapse because repeating the same addiction program without reassessing persistent psychiatric symptoms may miss part of the problem.
Medication Adherence Can Become a Relapse-Prevention Issue
Medication can play an important role in treatment for opioid use disorder or alcohol use disorder, but medications differ substantially and are not appropriate for every patient.
For opioid use disorder, evidence-based medications include buprenorphine, methadone and naltrexone. For alcohol use disorder, medications may include naltrexone, acamprosate and disulfiram in appropriate circumstances. Treatment selection requires individual medical assessment.
A practical issue is adherence. Someone may leave treatment intending to take medication exactly as prescribed and later begin missing tablets, appointments or repeat injections. That interruption can remove one layer of the recovery plan.
If medication was helpful but was stopped before a recurrence of use, that information should be discussed during the next clinical review. The question is not simply “Did the medication work?” but also “Was it taken or administered consistently enough to evaluate the treatment fairly?”
Opioid Tolerance Can Fall During Abstinence
A return to opioid use after detoxification, incarceration, residential treatment or another period of abstinence can be especially dangerous because opioid tolerance may have decreased.
A quantity that a person previously survived may become much more dangerous after tolerance falls. CDC identifies returning to a high opioid dose after loss of tolerance as a factor that can increase overdose risk.5
If opioid use has returned, treat overdose risk seriously
Do not assume the person’s previous dose is safe. Naloxone should be available where opioid exposure is possible, and people close to the individual should know where it is and how to use it. If an opioid overdose is suspected, administer naloxone if available, call 911, support breathing, place the person on their side when appropriate and stay with them until emergency help arrives.6
Overdose safety should be part of relapse planning even when the primary goal is abstinence. Planning for an emergency does not mean expecting recovery to fail. It means acknowledging that a recurrence of opioid use can have immediate medical consequences.
Is Repeating the Exact Same Treatment Always the Answer?
Sometimes repeating treatment is appropriate. A person may simply need renewed stabilization, another episode of residential care or a higher level of support.
But automatically repeating the identical approach without understanding what happened afterward can miss an opportunity to improve the plan.
NIDA describes recurrence of drug use as a reason to resume, modify or try another treatment rather than as proof that all previous treatment failed.7
Ask what worked
- Did withdrawal stabilize?
- Were cravings lower during treatment?
- Did therapy identify useful patterns?
- Did sleep and physical health improve?
- Did a medication appear helpful?
Ask where the plan weakened
- When did cravings become harder?
- Was medication stopped?
- Did counseling continue?
- Which people or places reappeared?
- Was daily life too unstructured?
For someone researching DeBinge’s Atlanta treatment guide, this previous history is particularly important. A different treatment pathway should be considered because it addresses a clinically relevant gap, not simply because it is different.
Build the Next Plan Around the Weakest Parts of the Previous One
A relapse review can be much more useful when it looks backward through the days and weeks before substance use returned.
What changed?
Sleep, stress, mood, work, family, money or relationships?
What disappeared?
Counseling, medication, meetings, exercise, structure or supportive contact?
What returned?
Old friends, old locations, substance access, secrecy or previous routines?
What needs strengthening?
Level of care, medication strategy, environment, therapy or accountability?
The next plan should translate those answers into concrete changes. “Try harder” is not a treatment modification. Increasing counseling frequency, changing the living environment, reviewing medication adherence, treating depression, adding structured activities or changing the level of care are actual modifications that can be discussed with professionals.
Where Might Naltrexone Fit After Repeated Relapse?
Naltrexone is an opioid antagonist used in approved oral and extended-release injectable forms for certain patients with opioid use disorder and alcohol use disorder.
For opioid use disorder, naltrexone blocks opioid receptors and can reduce the rewarding effects of opioids while adequate medication levels are present. Because it is an antagonist, a person who is physically dependent on opioids requires an adequate opioid-free period before naltrexone is started. Administering it too early can precipitate significant withdrawal.
For alcohol use disorder, naltrexone can reduce alcohol’s reinforcing effects and may help some patients reduce heavy drinking or support abstinence. It is not a treatment for acute alcohol withdrawal.
Naltrexone is not a guarantee against relapse or overdose
No naltrexone formulation should be presented as a cure or as permanent protection from overdose. Medication works best when considered within a wider plan that can include counseling, mental-health treatment, family or peer support, daily structure and continuing clinical care.
Different delivery methods also create different adherence questions. Oral naltrexone requires regular dosing. Extended-release injectable naltrexone such as Vivitrol is generally administered every four weeks. Longer-acting implant formulations are designed to provide sustained release for longer periods depending on the specific product.
Naltrexone implants are not FDA-approved in the United States. DeBinge’s implant-based treatment takes place in Nassau, The Bahamas, where clinically appropriate. It should not be assumed that an implant is suitable simply because someone previously relapsed.
A clinician should first consider the substance involved, physical dependence, prior medications, medical history, previous treatment, recovery goals and other evidence-based options.
Can Treatment Away From the Normal Environment Be Useful?
Some people decide that beginning another stage of treatment away from their normal environment could help create distance from immediate triggers and allow them to focus on treatment planning.
For an Atlanta resident, temporarily leaving familiar routines in Midtown, Buckhead, Decatur, Sandy Springs, Marietta or elsewhere in Metro Atlanta may provide a period in which everyday cues are less immediate.
But geography alone is not treatment.
A person can travel hundreds of miles and still carry the same addiction, mental-health symptoms, learned coping patterns and relationship difficulties with them. If treatment away from home is considered, its value should come from the clinical program and what is built during that time, not merely the change of scenery.
Atlanta residents exploring a different recovery pathway can review the Atlanta-to-Nassau treatment pathway to understand how assessment, preparation, treatment and planning for the return to Georgia are intended to connect.
Preparing to Return to Atlanta After Treatment
The recovery plan should not be written on the flight home.
Before returning to Atlanta, the person should know what the first day, first weekend and first difficult week are likely to look like.
People
Who supports recovery? Who increases risk? Which relationships need boundaries or temporary distance?
Places
Which locations are strongly connected with prior substance use, and can routes or routines be changed?
Time
Which hours are usually unstructured, lonely or high risk, and what will replace the old routine?
Treatment
When is the first counseling, medical or recovery-support appointment after returning?
Medication
What medication is being used, who monitors it and what happens if treatment is interrupted?
Emergency plan
Who is contacted if substance use resumes, cravings become severe or an overdose risk develops?
A Practical 30-Day, 90-Day and 180-Day Recovery Structure
Recovery plans become easier to use when they define what happens next rather than relying on a vague instruction to “stay focused.” The exact schedule should be individualized, but this framework can help start a discussion with a treatment team.
Stabilize and protect the routine
Prioritize scheduled treatment, medication adherence where prescribed, sleep, regular meals, safe housing, removal of easy substance access, frequent contact with supportive people and avoidance of known high-risk situations where practical.
Strengthen recovery skills
Use counseling to work on personal triggers, emotional regulation, relationships, coping strategies and the events that preceded previous relapse. Review whether the current level of care remains sufficient rather than assuming it should automatically decrease.
Prepare for confidence-related risks
As life becomes more normal, attention may shift away from recovery. Review boundaries, work stress, social events, travel, medication plans and thoughts such as “I am fine now, so I no longer need support.” Continuing care can be adjusted rather than abruptly abandoned.
Family Support Can Help Without Becoming Full-Time Surveillance
Repeated relapse can leave families frightened and exhausted. After previous treatment, relatives may begin watching every phone call, bank transaction or change in mood because they are afraid of another crisis.
Support is important, but relatives cannot personally control another adult’s recovery. A more sustainable role is to understand the treatment plan, recognize agreed warning signs, encourage engagement with professional help and maintain clear boundaries.
Families can ask:
- What usually changes before substance use returns?
- Who should be contacted when cravings increase?
- Is medication being followed as prescribed?
- What behavior represents an emergency rather than an ordinary difficult day?
- Where is naloxone kept if opioid exposure is possible?
- What boundaries protect other people in the household?
- Does the family itself need counseling or support?
Family involvement can be valuable, particularly when it helps the person speak earlier about increasing risk rather than feeling they must hide problems until another crisis has already developed.
What May Be Making Your Recovery Harder to Maintain?
Answer these questions to identify areas you may want to discuss with a doctor, counselor or recovery team. This is an educational planning tool, not a diagnostic test, and it cannot determine which treatment or medication you should receive.
Your answers are calculated inside this page. This quiz does not submit your answers to DeBinge.
1. Have you returned to substance use after previous treatment or periods of recovery?
2. How much do cravings interfere with your recovery?
3. What happens when you return to your normal social environment?
4. After detox or residential treatment, how consistently did continuing care continue?
5. If medication has been part of treatment, what best describes your experience?
6. Are anxiety, depression, trauma-related symptoms or other emotional difficulties affecting recovery?
7. What usually happens when stress becomes intense?
8. How structured is your day when you are at home?
9. Who knows when your recovery is becoming difficult?
10. If treatment began again, what would most need to be different afterward?
Your Recovery Review
Your answers highlight areas that may be worth discussing with a qualified addiction professional. The results do not diagnose a disorder, measure the severity of addiction or determine which treatment is appropriate.
Take these questions into your consultation
What was working before substance use returned? What changed first? Which part of continuing care became weaker? Are medication, mental health, environment, structure or support contributing? What specific part of the next treatment plan should be different?
Recovery Usually Needs Several Layers of Protection
Triggers & environment
Identify the people, places, emotions and situations that repeatedly increase risk and decide what can be changed before they appear.
Continuing care
Keep professional treatment connected to everyday life rather than waiting until another crisis has developed.
Medication review
Where clinically appropriate, discuss medication choices, adherence problems, duration and what happened during previous treatment.
Mental health
Persistent psychiatric or emotional symptoms may require assessment and integrated treatment alongside addiction care.
Structure & support
Build predictable routines and make sure someone knows when recovery is becoming more difficult.
Reassessment
If several areas are weak at the same time, the next step may require a broader treatment review rather than one isolated change.
Explore a Different Treatment Pathway Without Assuming It Is Automatically the Right One
If detox, rehab or another treatment episode did not produce the sustained outcome you hoped for, the next step should begin with understanding what happened rather than simply repeating the same plan automatically.
DeBinge offers an alternative pathway for some Atlanta residents who are considering treatment in Nassau, The Bahamas. The process begins with clinical discussion and assessment. Where medically appropriate, the programme may include sustained-release naltrexone alongside counseling and longer-term recovery planning.
DeBinge does not operate a treatment facility in Atlanta, and previous relapse does not mean that an implant or any other particular medication will be suitable. Local Georgia treatment, outpatient care, residential care, methadone, buprenorphine, approved naltrexone formulations or other approaches may be more appropriate depending on the individual.
The purpose of a consultation is to understand the history, identify what may need to change and discuss whether the pathway is worth considering before any travel is arranged.
View Treatment Planning for People Travelling From AtlantaRelapse After Rehab or Detox in Atlanta: FAQ
1. Why did I relapse even though I completed rehab?
There is rarely one explanation. Factors can include persistent cravings, exposure to familiar triggers, insufficient continuing care, untreated mental-health needs, medication interruption, stress, isolation, unstable housing, lack of daily structure or a treatment approach that did not fully match your needs. The useful next step is to review what happened before and after discharge.
2. Does relapse mean rehab did not work?
Not necessarily. Treatment may have produced important improvements while it was active. A return to use can indicate that treatment needs to be resumed, adjusted or supplemented. Previous treatment can also provide valuable information about what helped and where additional protection is needed.
3. Is detox enough to treat addiction?
Usually not. Detoxification primarily manages withdrawal and acute physical stabilization. NIDA guidance explains that detox alone does not typically address the psychological, social and behavioral aspects of addiction, so ongoing treatment is generally needed.
4. Why are the first weeks after returning home difficult?
The structured treatment environment disappears while normal stress, responsibilities, substance access and familiar triggers return. A detailed continuing-care and relapse-prevention plan can help bridge this transition.
5. Is repeated relapse a sign that recovery is impossible?
No. Repeated return to use can indicate that important parts of treatment need reassessment. This may include level of care, medication, mental-health treatment, continuing care, environment, housing, social relationships or daily structure.
6. Should I go back to the same rehab after relapse?
That may be appropriate in some circumstances, but it should not be assumed automatically. Ask what the previous treatment accomplished, when difficulties returned and what would be changed in another treatment episode. A clinician can help determine whether the same, higher, lower or different level of care is appropriate.
7. Why is opioid relapse especially dangerous after abstinence?
Opioid tolerance can decrease during a period without opioids. Returning to an amount previously tolerated may then cause overdose. Naloxone access and overdose education are important where opioid exposure remains possible.
8. Can medication help prevent another relapse?
Medication can be an important component of treatment for some people with opioid use disorder or alcohol use disorder. The appropriate medication depends on the individual, and medication should generally be combined with broader treatment and recovery support rather than viewed as a complete recovery plan on its own.
9. Can naltrexone be used after opioid addiction?
Naltrexone can be used for appropriately selected patients with opioid use disorder after adequate opioid-free preparation. Because it blocks opioid receptors, starting it while a person remains physically dependent on opioids can precipitate withdrawal. Medical assessment is required.
10. Is a naltrexone implant available at a DeBinge clinic in Atlanta?
No. DeBinge does not operate an implant clinic in Atlanta or elsewhere in Georgia. DeBinge implant-based treatment takes place in Nassau, The Bahamas. Naltrexone implant products are not FDA-approved in the United States.
11. Why would someone from Atlanta consider temporary treatment away from home?
Some people value temporary distance from the people, places and routines associated with previous substance use. That can create space for treatment and planning, but travel itself is not treatment. The clinical program and the plan for returning home remain essential.
12. What should be different after another treatment episode?
The answer should come from reviewing the previous episode. Possible changes include stronger continuing care, different medication management, treatment of co-occurring mental-health needs, a safer living environment, more structured days, family involvement, better trigger planning or a different level of care.
13. How quickly should treatment be restarted after a relapse?
If substance use has returned, contacting an addiction professional promptly can reduce the time spent outside treatment and allow medical risks to be assessed. Immediate emergency symptoms such as suspected overdose, difficulty breathing, unconsciousness, seizures or severe withdrawal require emergency care rather than waiting for a routine appointment.
14. What should an Atlanta family do if a loved one keeps relapsing?
Gather clear information about substances, previous treatment, medication, overdose or withdrawal history and what typically happens before substance use returns. Encourage a professional reassessment, maintain reasonable boundaries and make sure the household understands emergency and naloxone procedures where opioid exposure is possible.
Evidence Behind This Guide
NIDA guidance explaining that detoxification is generally the first stage of treatment and does not by itself address the psychological, social and behavioral aspects of addiction.
Read the NIDA treatment principles
Review of controlled trials examining the effectiveness of continuing care following initial substance use disorder treatment.
View the study on PubMed
Review examining continuing care, duration, engagement and the need to reassess treatment as patient circumstances change.
Read the PubMed review
Guidance supporting integrated assessment and treatment when mental-health and substance-use conditions occur together.
Read SAMHSA guidance
CDC information identifying return to higher opioid doses after loss of tolerance as an overdose risk factor.
Read CDC opioid safety information
Practical guidance covering naloxone, calling 911, supporting breathing, recovery positioning and staying with the person until emergency help arrives.
Read CDC overdose-response guidance
Patient-focused guidance explaining that return to substance use can indicate a need to resume or modify treatment rather than conclude that treatment has failed.
Read the NIDA treatment guide
A 2026 systematic review and meta-analysis examining factors associated with relapse after residential substance-use treatment, including psychological distress, self-efficacy, treatment duration and peer support.
View the research on PubMed
Medical and emergency information
This article is general educational information and does not replace medical assessment, diagnosis or treatment. Do not abruptly stop alcohol, opioids, benzodiazepines, methadone, buprenorphine or prescribed medication simply to prepare for treatment or travel.
If someone is unconscious, has difficulty breathing, is experiencing a suspected overdose, seizure, severe confusion, severe withdrawal or another immediate medical emergency in the United States, call 911. If opioid overdose is possible, administer naloxone if available and follow emergency-dispatch instructions. For immediate suicide or mental-health crisis support in the United States, call or text 988.
Prepared for Medical Review by Dr Fergus Law, BSc, MBChB, FRCPsych
Dr Fergus Law is a Consultant Psychiatrist specialising in substance misuse and addiction psychiatry. His clinical experience supports the medical review of DeBinge educational content relating to addiction treatment, opioid dependence, relapse prevention and medication-based approaches.
Review status: Pending clinical approval
View Dr Fergus Law’s Clinical & Scientific Profile →This article is intended for education and does not replace individualized medical assessment, diagnosis or treatment from a qualified healthcare professional.